Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Total Current Liabilities (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Total Current Liabilities for 8 consecutive years, with $8.9 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 40.5% to $8.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.9 million through Dec 2025, down 40.5% year-over-year, with the annual reading at $8.9 million for FY2025, 40.5% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $8.9 million at Precision Biosciences, down from $15.0 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $63.8 million in Q1 2021, with the low at $8.9 million in Q4 2025.
  • Average Total Current Liabilities over 5 years is $36.2 million, with a median of $36.1 million recorded in 2021.
  • The sharpest move saw Total Current Liabilities soared 168.54% in 2021, then plummeted 76.33% in 2024.
  • Over 5 years, Total Current Liabilities stood at $36.0 million in 2021, then skyrocketed by 65.83% to $59.7 million in 2022, then fell by 16.22% to $50.0 million in 2023, then tumbled by 70.03% to $15.0 million in 2024, then tumbled by 40.5% to $8.9 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $8.9 million, $15.0 million, and $13.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.